Clinical Trial Update: Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effect of alendronate on vascular calcification and arterial stiffness in patients with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Chronic Kidney Disease
• Vascular Calcification

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Monash University | Conditions: Vascular Calcification, Arteriosclerosis | Phase 4 | Status: COMPLETED